Literature DB >> 18653825

Dissociation between superoxide accumulation and nitroglycerin-induced tolerance.

Pei-Suen Tsou1, Vamsi Addanki, Ho-Leung Fung.   

Abstract

We hypothesize that superoxide (O(2)(*-)) accumulation is not a crucial causative factor in inducing nitroglycerin (NTG) tolerance. In LLC-PK1 cells, pre-exposure to NTG resulted in increased O(2)(*-) accumulation and reduced cGMP response to NTG versus vehicle control. O(2)(*-) stimulated by NTG was reduced by oxypurinol (100 microM), a xanthine oxidase inhibitor. Exposure to angiotensin II (Ang II) increased O(2)(*-) but did not reduce cGMP response. The O(2)(*-) scavenger tiron reduced Ang II-induced O(2)(*-) production but did not increase NTG-stimulated cGMP production. Using p47(phox-/-) and gp91(phox-/-) mice versus their respective wild-type controls (WT), we showed that aorta from mice null of these critical NADPH oxidase subunits exhibited similar vascular tolerance after NTG dosing (20 mg/kg s.c., t.i.d. for 3 days), as indicated by their ex vivo pEC(50) and cGMP accumulation upon NTG challenge. In vitro aorta O(2)(*-) production was enhanced by NTG incubation in both p47(phox) null and WT mice. Pre-exposure of isolated mice aorta to 100 microM NTG for 1 h resulted in vascular tolerance toward NTG and increased O(2)(*-) accumulation. Oxypurinol (1 mM) reduced O(2)(*-) but did not attenuate vascular tolerance. These results suggest that O(2)(*-) does not initiate either in vitro and in vivo NTG tolerance, and that the p47(phox) and gp91(phox) subunits of NADPH oxidase are not critically required. Increased O(2)(*-) accumulation may be an effect, rather than an initiating cause, of NTG tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653825      PMCID: PMC2574757          DOI: 10.1124/jpet.108.138784

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.

Authors:  Giancarlo Longobardi; Nicola Ferrara; Dario Leosco; Pasquale Abete; Giuseppe Furgi; Francesco Cacciatore; Graziamaria Corbi; Raffaella Pescatore; Franco Rengo
Journal:  Cardiovasc Drugs Ther       Date:  2004-09       Impact factor: 3.727

2.  Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.

Authors:  N Dakak; N Makhoul; M Y Flugelman; A Merdler; H Shehadeh; A Schneeweiss; D A Halon; B S Lewis
Journal:  Am J Cardiol       Date:  1990-09-01       Impact factor: 2.778

3.  Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.

Authors:  Andreas Daiber; Matthias Oelze; Meike Coldewey; K Kaiser; C Huth; S Schildknecht; M Bachschmid; Y Nazirisadeh; V Ullrich; A Mülsch; T Münzel; N Tsilimingas
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

Review 4.  Explaining the phenomenon of nitrate tolerance.

Authors:  Thomas Münzel; Andreas Daiber; Alexander Mülsch
Journal:  Circ Res       Date:  2005-09-30       Impact factor: 17.367

Review 5.  The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction.

Authors:  Mark T Quinn; Mary Cloud B Ammons; Frank R Deleo
Journal:  Clin Sci (Lond)       Date:  2006-07       Impact factor: 6.124

6.  Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance.

Authors:  Philip Wenzel; Ulrich Hink; Matthias Oelze; Swaantje Schuppan; Karin Schaeuble; Stefan Schildknecht; Kwok K Ho; Henry Weiner; Markus Bachschmid; Thomas Münzel; Andreas Daiber
Journal:  J Biol Chem       Date:  2006-11-13       Impact factor: 5.157

7.  Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.

Authors:  B M Bennett; D C Leitman; H Schröder; J H Kawamoto; K Nakatsu; F Murad
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

8.  Superoxide radical production by allopurinol and xanthine oxidase.

Authors:  Chiara Galbusera; Peter Orth; David Fedida; Thomas Spector
Journal:  Biochem Pharmacol       Date:  2006-02-23       Impact factor: 5.858

9.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Authors:  S Rajagopalan; S Kurz; T Münzel; M Tarpey; B A Freeman; K K Griendling; D G Harrison
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

10.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

Authors:  T Münzel; H Sayegh; B A Freeman; M M Tarpey; D G Harrison
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  3 in total

1.  Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites.

Authors:  Pei-Suen Tsou; Nathaniel A Page; Sean G Lee; Sun Mi Fung; Wing Ming Keung; Ho-Leung Fung
Journal:  AAPS J       Date:  2011-08-05       Impact factor: 4.009

2.  Role of glutaredoxin-mediated protein S-glutathionylation in cellular nitroglycerin tolerance.

Authors:  Pei-Suen Tsou; Vamsi Addanki; Jessica A Haas; Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharmacol Exp Ther       Date:  2009-02-17       Impact factor: 4.030

3.  Berberine Reverses Nitroglycerin Tolerance through Suppressing Protein Kinase C Alpha Activity in Vascular Smooth Muscle Cells.

Authors:  Huina Zhang; Jinghui Dong; Chi-Wai Lau; Yu Huang
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.